Next Article in Journal
Treating Pulmonary Fibrosis with Non-Viral Gene Therapy: From Bench to Bedside
Next Article in Special Issue
Relevance of Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in Routine Clinical Practice: A Pilot Study
Previous Article in Journal
Highway to Cell: Selection of the Best Cell-Penetrating Peptide to Internalize the CFTR-Stabilizing iCAL36 Peptide
Previous Article in Special Issue
Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(4), 811; https://doi.org/10.3390/pharmaceutics14040811
Action Date Notes Link
article xml file uploaded 7 April 2022 12:43 CEST Original file -
article xml uploaded. 7 April 2022 12:43 CEST Update https://www.mdpi.com/1999-4923/14/4/811/xml
article pdf uploaded. 7 April 2022 12:43 CEST Version of Record https://www.mdpi.com/1999-4923/14/4/811/pdf
article supplementary file uploaded. 7 April 2022 12:43 CEST - https://www.mdpi.com/1999-4923/14/4/811#supplementary
article html file updated 7 April 2022 12:45 CEST Original file -
article html file updated 2 August 2022 17:41 CEST Update https://www.mdpi.com/1999-4923/14/4/811/html
Back to TopTop